Posted by Equitymaster Share markets in India ended the day on a flat note after the Nifty 50 hit the crucial 10,000 mark for the first time ever.... ...http://www.equitymaster.com/tm/tm.asp?date=7/25/2017&title=Nifty-Ends-Flat-After-Hitting-10000-Mark-Where-Should-You-Invest-Now
The company "has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for losartan... ...http://www.moneycontrol.com/news/business/unichem-lab-gets-usfda-nod-for-hypertension-drug_9326021.html
By Tanya Agrawal (Reuters) - The S&P 500 and the Dow Jones Industrial Average were pulled lower by losses in Johnson & Johnson in late morning... ...http://www.sify.com/finance/sp-dow-lower-as-johnson--johnson-drags-news-equity-rhytbEfgebdhj.html
U.S. Food and Drug Administration (FDA) scientists on Monday expressed concern that Intellipharmaceutics International Inc had failed to provide... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/wfnUJIWfKUg/us-intellipharma-fda-idINKBN1A91RT
Posted by Equitymaster Share markets in India continued their upward climb in afternoon trade. At the closing bell, the BSE Sensex closed higher by... ...http://www.equitymaster.com/tm/tm.asp?date=7/24/2017&title=Sensex--Nifty-Hit-Record-Highs-Are-Stocks-Expensive-Now
An additional reason precisely why...